IMPACT OF ADJUVANT CHEMOTHERAPY AND SURGICAL STAGING IN EARLY-STAGE OVARIAN CARCINOMA: EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER – ADJUVANT CHEMOTHERAPY IN OVARIAN NEOPLASM TRIAL

TRIM BUS, J.B., VERGOTE, I., & BOLIS, G.. (2003). IMPACT OF ADJUVANT CHEMOTHERAPY AND SURGICAL STAGING IN EARLY-STAGE OVARIAN CARCINOMA: EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER – ADJUVANT CHEMOTHERAPY IN OVARIAN NEOPLASM TRIAL. JOURNAL OF THE NATIONAL CANCER INSTITUTE (JNCI), 95(2), 94-95. SID. https://sid.ir/paper/570931/en

TRIM BUS J.B., VERGOTE I., BOLIS G.. IMPACT OF ADJUVANT CHEMOTHERAPY AND SURGICAL STAGING IN EARLY-STAGE OVARIAN CARCINOMA: EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER – ADJUVANT CHEMOTHERAPY IN OVARIAN NEOPLASM TRIAL. JOURNAL OF THE NATIONAL CANCER INSTITUTE (JNCI)[Internet]. 2003;95(2):94-95. Available from: https://sid.ir/paper/570931/en

J.B. TRIM BUS, I. VERGOTE, and G. BOLIS, “IMPACT OF ADJUVANT CHEMOTHERAPY AND SURGICAL STAGING IN EARLY-STAGE OVARIAN CARCINOMA: EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER – ADJUVANT CHEMOTHERAPY IN OVARIAN NEOPLASM TRIAL,” JOURNAL OF THE NATIONAL CANCER INSTITUTE (JNCI), vol. 95, no. 2, pp. 94–95, 2003, [Online]. Available: https://sid.ir/paper/570931/en